Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of the carbon footprint and cost-effectiveness of endoscopic liquid waste processing methods.

Endoscopy·2025
Same author

The triple association of sickle cell disease, primary sclerosing cholangitis and inflammatory bowel disease (SCD-PSC-IBD): iceberg in sight.

Clinics and research in hepatology and gastroenterology·2025
Same author

Clinical use of per ERCP bile aspiration in patients with cholangitis: The aspibile study.

Clinics and research in hepatology and gastroenterology·2025
Same author

Effectiveness of medical treatments depending on Crohn's disease location. That is the question.

Clinics and research in hepatology and gastroenterology·2025
Same author

Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort.

Journal of Crohn's & colitis·2024
Same author

Pancreatic rendezvous technique for treating a disconnected pancreatic duct syndrome in a patient with ansa pancreatica.

Endoscopy·2024

Related Experiment Video

Updated: May 31, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Bacteria as trigger for chronic gastrointestinal disorders.

Philippe Marteau1, Ulriikka Chaput

  • 1AP-HP, Lariboisière Hospital, Department of Digestive Diseases, Paris 7 University, Paris, France. philippe.marteau@lrb.aphp.fr

Digestive Diseases (Basel, Switzerland)
|July 8, 2011
PubMed
Summary

Microorganisms can cause chronic gastrointestinal inflammation, leading to cell proliferation and diseases like cancer. Understanding gut microbiota through metagenomics and metabolomics offers new insights into conditions such as irritable bowel syndrome and obesity.

More Related Videos

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Related Experiment Videos

Last Updated: May 31, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

Area of Science:

  • Microbiology
  • Gastroenterology
  • Oncology

Background:

  • Microorganisms can trigger chronic inflammation and cell proliferation in the gastrointestinal tract, potentially leading to cancer.
  • Specific bacteria like Helicobacter pylori are implicated in gastric adenocarcinoma and lymphoma development.
  • Dysbiosis, an imbalance in gut microbiota, is frequently observed in inflammatory bowel diseases.

Purpose of the Study:

  • To explore the role of microorganisms in chronic gastrointestinal diseases, including cancer and inflammatory conditions.
  • To discuss the mechanisms of microbial-induced carcinogenesis and lymphoma genesis.
  • To highlight the potential of new tools like metagenomics and metabolomics in understanding gastrointestinal ecosystems.

Main Methods:

  • Review of existing literature on microbial involvement in gastrointestinal diseases.
  • Analysis of factors contributing to microbial carcinogenesis and lymphoma.
  • Discussion of diagnostic markers and prognostic indicators in inflammatory bowel disease.

Main Results:

  • Helicobacter pylori is linked to gastric adenocarcinoma and lymphoma, with a multi-step carcinogenic process involving host, environment, and bacterial factors.
  • Campylobacter jejuni plays a role in immunoproliferative small bowel disease, potentially curable by eradication.
  • Dysbiosis, characterized by instability and reduced biodiversity (e.g., decreased Faecalibacterium prausnitzii), is a hallmark of inflammatory bowel disease.

Conclusions:

  • Microbial infections and dysbiosis are significant factors in the pathogenesis of various gastrointestinal diseases, including cancers and inflammatory conditions.
  • Early eradication of certain bacteria can be curative for specific lymphomas.
  • Advanced tools like metagenomics and metabolomics are crucial for future research in gastrointestinal health, focusing on IBS, colon cancer, and obesity.